A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2009
12/10/2009	WO2009147211A1 New compounds v
12/10/2009	WO2009147121A1 Carboxyl substituted indoles for use as ppar alpha modulators
12/10/2009	WO2009146772A1 New terpenes and macrocycles
12/10/2009	WO2009146540A1 N-piperidinyl acetamide derivatives as calcium channel blockers
12/10/2009	WO2009146539A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/10/2009	WO2009125017A3 Process for the extraction of mangiferin and isomangiferin
12/10/2009	WO2009118759A3 Heterocyclic compounds as adenosine receptor antagonist
12/10/2009	WO2009114718A3 Methods and assays for detecting and treating hypoglycemia
12/10/2009	WO2009110983A3 Retinaldehyde in the treatment of obesity, diabetes and other conditions
12/10/2009	WO2009109616A3 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
12/10/2009	WO2009097443A3 Liquid formulations of compounds active at sulfonylurea receptors
12/10/2009	WO2009073138A3 Treatment of metabolic syndrome with novel amides
12/10/2009	WO2009054994A3 Use of compounds activating sirt-3 for mimicking exercise
12/10/2009	US20090306221 Use for Cannabinoid
12/10/2009	US20090306212 Compositions and Methods for Treating Diabetes and Neuropsychological Dysfunction
12/10/2009	US20090306179 Compounds and methods for modulating expression of gcgr
12/10/2009	US20090306155 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
12/10/2009	US20090306133 New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087
12/10/2009	US20090306117 Rosuvastatin zinc salt
12/10/2009	US20090306075 Chemical compounds
12/10/2009	US20090306070 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use
12/10/2009	US20090306063 Oxadiazoanthracene Compounds For The Treatment Of Diabetes
12/10/2009	US20090306048 Pharmaceutical use of substituted piperidine carboxamides
12/10/2009	US20090306037 Combination of a Dipeptidyl Peptidase-IV Inhibitor and a Cannabinoid CB1 Receptor Antagonist for the Treatment of Diabetes and Obesity
12/10/2009	US20090305992 Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
12/10/2009	US20090305991 33 Human Secreted Proteins
12/10/2009	US20090305960 Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
12/10/2009	US20090305951 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells
12/10/2009	US20090305945 Novel nutraceutical compositions
12/10/2009	US20090305365 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
12/10/2009	US20090305225 Inhibition of Creatine Uptake to Promote Weight Loss
12/10/2009	US20090304830 Composition Comprising Bamboo Extract for Androgen Agonist
12/10/2009	US20090304822 Extract of Polygonum multiflorum Thunb. ex Murray var. hypoleucum and compositions for improving metabolic syndrome
12/10/2009	US20090304790 Controlled release pharmaceutical compositions comprising a fumaric acid ester
12/10/2009	US20090304789 Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders
12/10/2009	US20090304654 Methods for isolating adipose-derived stem cells and therapeutic use thereof
12/10/2009	DE102008027331A1 Verwendung von Indol-3-carbonsäureestern zur Hemmung der mikrosomalen Prostaglandin E2 Synthase The use of indole-3-carboxylic acid esters to inhibit the microsomal prostaglandin E2 synthase
12/10/2009	CA2728423A1 Respiratory syncytial virus renders dendritic cells tolerogenic
12/10/2009	CA2726883A1 New terpenes and macrocycles
12/10/2009	CA2726706A1 Water-soluble extracts of artemisia dracunculus (tarragon) for improvement of glucose metabolism
12/10/2009	CA2726646A1 New compounds vii
12/10/2009	CA2726644A1 Pharmaceutical combination
12/10/2009	CA2726589A1 Fgf21 mutants and uses thereof
12/10/2009	CA2726441A1 New pyridine derivatives as leptin receptor modulator mimetics
12/10/2009	CA2726270A1 Small molecule leptin receptor modulators
12/10/2009	CA2725749A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
12/10/2009	CA2725316A1 Novel isoxazole derivative
12/10/2009	CA2722723A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/09/2009	EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer
12/09/2009	EP2130830A1 Muscarinic receptor antagonists
12/09/2009	EP2130829A1 Novel hydroxyindole derivative
12/09/2009	EP2130825A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof
12/09/2009	EP2130548A2 Growth Hormone Releasing Peptides
12/09/2009	EP2130544A2 Processes for obtaining lignan extracts and compositions containing the lignan extracts
12/09/2009	EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009	EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009	EP2130443A1 Water-soluble extracts of Artemisia dracunculus (tarragon) for improvement of glucose metabolism
12/09/2009	EP2129687A2 Novel glp-1 fusion peptides, their production and use
12/09/2009	EP2129668A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
12/09/2009	EP2129654A1 Novel antagonists of the glucagon receptor
12/09/2009	EP2129652A2 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
12/09/2009	EP2129386A1 Probiotics for reduction of risk of obesity
12/09/2009	EP2129374A1 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
12/09/2009	EP1861113B1 Use of an onion extract for making a composition to control weight gain
12/09/2009	EP1554256B1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
12/09/2009	EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/09/2009	EP1252144B1 Substituted glutarimides and use thereof il-12 production inhibitors
12/09/2009	EP1129110B1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
12/09/2009	EP1119614B1 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof
12/09/2009	CN201356817Y Coptis-coated insulin granule
12/09/2009	CN101600724A Nk1 receptor antagonist composition
12/09/2009	CN101600715A Compounds having both angiotensin ii receptor antagonism and ppary activating activities
12/09/2009	CN101600708A Organic compounds
12/09/2009	CN101600700A Novel 2-aminooxazolines as TAAR1 ligands for CNS disorders
12/09/2009	CN101600688A Atorvastatin strontium salt and pharmaceutical composition comprising same
12/09/2009	CN101600440A Pharmaceutical composition comprising a pyrazole-O-glucoside derivative
12/09/2009	CN101600427A Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
12/09/2009	CN101600424A Pharmaceutical composition containing naphthoquinone-based compound for intestine delivery system
12/09/2009	CN101597389A Mixture of momordica saponins and polysaccharides and extraction process and application thereof
12/09/2009	CN101597337A Conjugate of hydroxyalkyl starch and an active agent
12/09/2009	CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/09/2009	CN101597217A PTP1B inhibitor as well as synthesis method and application thereof in preparation of medicine for curing type 2 diabetes
12/09/2009	CN101597216A Brominated PTP1B inhibitor as well as synthesis method and application thereof in preparation of medicine for curing type 2 diabetes
12/09/2009	CN101597213A Chemical synthesis method of bromphenol PTP1B inhibitor
12/09/2009	CN101597212A Kirenol derivative and application thereof in preparation of proinflammatory cytokine inhibitor
12/09/2009	CN101596317A Composition containing tanshinone ingredient and HMG-CoA reductase inhibitor and application thereof
12/09/2009	CN101596294A Emulsification adlay oil capable of inhibiting cholesterin and enhancing high-density lipoprotein and manufacture method thereof
12/09/2009	CN101596292A Oral liquid for tonifying spleen and beautifying
12/09/2009	CN101596287A Drug combination for reducing blood sugar and lipid levels
12/09/2009	CN101596286A Drug combination for reducing blood sugar and lipid levels
12/09/2009	CN101596285A Drug combination for reducing blood sugar and lipid levels
12/09/2009	CN101596284A Drug combination for reducing blood sugar and lipid levels
12/09/2009	CN101596283A Drug combination for reducing blood sugar and lipid levels
12/09/2009	CN101596282A Drug combination for reducing blood sugar and lipid levels
12/09/2009	CN101596281A Drug combination for reducing blood sugar and lipid levels
12/09/2009	CN101596280A Drug combination for reducing blood sugar and lipid levels and treating diabetes
12/09/2009	CN101596279A Drug combination for reducing blood sugar and lipid levels and treating diabetes
12/09/2009	CN101596278A Drug combination for reducing blood sugar and lipid levels and treating diabetes
12/09/2009	CN101596277A Drug combination for reducing blood sugar and lipid levels and treating diabetes
12/09/2009	CN101596276A Drug combination for reducing blood sugar and lipid levels and treating diabetes

1 ... 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 ... 1298